[The risk of malignancy after organ transplantation].
Improvements in immunosuppressive therapy during the past decade brought about improvements of the long term tolerance of organ allografts. However, the long-term immunosuppressive therapy has an important limitation, because it can increase the risk of cardivascular diseases, infections and tumors. As compared with age-matched healthy population, organ-transplant recipients have an increased incidence of tumors.
Gürlich
R
R
Klinika transplantacní chirurgie IKEM, Praha. robert.gurlich@ikem.cz
Novotný
J
J
Stríz
I
I
Honsová
E
E
Oliverius
M
M
Janousek
L
L
Pokorná
E
E
Maruna
P
P
D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D009369:Neoplasms / Q000209:etiology*; D016377:Organ Transplantation / Q000009:adverse effects*; D012307:Risk Factors; D014181:Transplantation Immunology
D007166:Immunosuppressive Agents